Skip to main content
Fig. 9 | BMC Complementary Medicine and Therapies

Fig. 9

From: Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease via inhibiting oxidative stress

Fig. 9

Effect of the intraperitoneal administration of thymol for 15 days on GSH (a) and MDA (b) levels in the striatum of the 6-OHDA-lesioned rats. Each measurement was done at least in triplicate, and the values are presented by means ± SD for six rats in each group. *p < 0.05, **p < 0.01 and ***p < 0.001 versus the untreated control group; # p < 0.05 and ###p < 0.01 versus the 6-OHDAtreated groups

Back to article page